Literature DB >> 8288783

The pathogenesis and clinical significance of xanthelasma palpebrarum.

R Bergman1.   

Abstract

Xanthelasma palpebrarum is the most common type of xanthoma. On average, only half the patients with xanthelasma palpebrarum are hyperlipidemic. This review is an attempt to elucidate the pathogenesis and clinical significance of xanthelasma palpebrarum, especially its suggested role as a marker for increased risk for atherosclerosis. In hyperlipidemic patients with xanthelasma, the risk for atherosclerosis may be inferred from the associated lipoprotein and apolipoprotein abnormalities. The possible risk for atherosclerosis in normolipidemic patients with xanthelasma is more obscure because of the relative paucity of epidemiologic data and the conflicting results in some of the lipid studies. Several studies, however, showed decreased high-density lipoprotein cholesterol levels and other lipoprotein and apolipoprotein abnormalities that are associated with atherosclerosis. Therefore, on the basis of the present data, determining the plasma lipoprotein and apolipoprotein levels (especially those associated with increased risk for atherosclerosis) in each normolipidemic patient with xanthelasma appears to be justified.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8288783     DOI: 10.1016/s0190-9622(94)70023-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  16 in total

1.  Xanthelasma Palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi.

Authors:  A Jain; P Goyal; P K Nigam; H Gurbaksh; R C Sharma
Journal:  Indian J Clin Biochem       Date:  2007-09

2.  Laser treatment of giant xanthelasma palpebrarum.

Authors:  Bartolo Corradino; Sara Di Lorenzo; Antonio Triolo; Francesco Moschella
Journal:  Lasers Med Sci       Date:  2014-09-25       Impact factor: 3.161

3.  Inflammatory Mediators in Xanthelasma Palpebrarum: Histopathologic and Immunohistochemical Study.

Authors:  Maria S Govorkova; Tatyana Milman; Gui-Shuang Ying; Wei Pan; Rona Z Silkiss
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2018 May/Jun       Impact factor: 1.746

4.  Bilateral extensive nodular xanthelasma palpebrarum: an infrequent case report.

Authors:  Pei Wang; Qingli Luo; Li Tang
Journal:  Int Ophthalmol       Date:  2017-04-03       Impact factor: 2.031

5.  Periorbital Hyperpigmentation in Patients with Xanthelasma Palpebrarum: An Interesting Observation.

Authors:  Eftychia Platsidaki; Anargyros Kouris; Efthymia Agiasofitou; Christina Antoniou; Georgios Kontochristopoulos
Journal:  J Clin Aesthet Dermatol       Date:  2016-04-01

6.  Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum.

Authors:  Hossein Kavoussi; Ali Ebrahimi; Mansour Rezaei; Mazaher Ramezani; Behnaz Najafi; Reza Kavoussi
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

7.  [Eruptive xanthomas with hypertriglyceridemia].

Authors:  R Renner; I Teuwen; W Harth; R Treudler; J C Simon
Journal:  Hautarzt       Date:  2008-12       Impact factor: 0.751

8.  Xanthelasma Palpebrarum: More than Meets the Eye.

Authors:  Shailesh Khode; Soon Heng Terry Tan; En-Pei Amanda Tan; Sandeep Uppal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-07

9.  Outcomes of surgical management of xanthelasma palpebrarum.

Authors:  Hoon Young Lee; Ung Sik Jin; Kyung Won Minn; Young-Oh Park
Journal:  Arch Plast Surg       Date:  2013-07-17

10.  The Significance of Extracellular Cholesterol Crystals or a Cholesterol Granuloma in Xanthelasma.

Authors:  Frederick A Jakobiec; Lina Ma; Natalie Wolkow; Francis C Sutula; Suzanne K Freitag
Journal:  Ocul Oncol Pathol       Date:  2018-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.